BRCA2 and breast cancer: The Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) is a widely used breast cancer risk assessment tool in European genetics clinics4, and its validity to predict the likelihood of PVs in BRCA1 and BRCA2 has been demonstrated in several large-scale studies5,6.